Assembly Biosciences ASMB Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Assembly Biosciences's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Assembly Biosciences's operating lease right-of-use assets in other assets?
- Assembly Biosciences (ASMB) reported operating lease right-of-use assets in other assets of $2.37M in Q1 2026.
- How has Assembly Biosciences's operating lease right-of-use assets in other assets changed year-over-year?
- Assembly Biosciences's operating lease right-of-use assets in other assets decreased by 19.1% year-over-year, from $2.93M to $2.37M.
- What is the long-term trend for Assembly Biosciences's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Assembly Biosciences's operating lease right-of-use assets in other assets has grown at a -22.8% compound annual growth rate (CAGR), from $9.13M to $2.51M.